FAIR VALUE DISCLOSURES (Tables)
|
3 Months Ended |
Mar. 31, 2025 |
Fair Value Disclosures [Abstract] |
|
Schedule of Weighted Average Interest Rate of Performing and All Loans |
The following tables show the weighted-average interest rate of the performing loans and all loans: | | | | | | | | | | | | | | | | | | | | | For the Three Months Ended | | | Performing Loans | | March 31, 2025 | | March 31, 2024 | | | | | Weighted-Average Interest Rate – Cash | | 11.82 | % | | 13.78 | % | | | | | Weighted Average Interest Rate – Non-Cash | | 2.84 | % | | 3.30 | % | | | | | Weighted-Average Interest Rate | | 14.66 | % | | 17.08 | % | | | | |
| | | | | | | | | | | | | | | | | | | | | For the Three Months Ended | | | All Loans | | March 31, 2025 | | March 31, 2024 | | | | | Weighted-Average Interest Rate – Cash | | 6.94 | % | | 12.15 | % | | | | | Weighted Average Interest Rate – Non-Cash | | 1.66 | % | | 2.90 | % | | | | | Weighted-Average Interest Rate | | 8.60 | % | | 15.05 | % | | | | |
|
Schedule of Fair Value Measurement Inputs and Valuation Techniques |
The following tables provide quantitative information about the Fund’s Level 3 fair value measurements of the Fund’s investments by industry as of March 31, 2025 and December 31, 2024. In addition to the techniques and inputs noted in the tables below, the Fund may also use other valuation techniques and methodologies when determining its fair value measurements.
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Investment Type - Level 3 | | | | | | | | | Loan Investments | | Fair Value at March 31, 2025 | | Valuation Techniques / Methodologies | | Unobservable Input | | Range | | Weighted Average (a) | Biotechnology | | $2,438,102 | | Most advantageous market analysis | | Most advantageous market coupon rate | | 15% - 16% | | 15% | Computers & Storage | | 9,590,508 | | Most advantageous market analysis | | Most advantageous market coupon rate | | 15%* | | 15% | | | | | Asset Recovery | | Probability weighting of alternative outcomes | | 30% - 40%* | | | Enterprise Networking | | 3,216,183 | | Asset Recovery | | Probability weighting of alternative outcomes | | 10% - 50% * | | | Internet | | 26,890,039 | | Most advantageous market analysis | | Most advantageous market coupon rate | | 18% - 20% | | 19% | | | Asset Recovery | | Probability weighting of alternative outcomes | | 5% - 100%^ | | | Medical Devices | | — | | Asset Recovery | | Probability weighting of alternative outcomes | | 100%^ | | | Other Healthcare | | 2,771,988 | | Most advantageous market analysis | | Most advantageous market coupon rate | | 12% - 22% | | 17% | | | Asset Recovery | | Probability weighting of alternative outcomes | | 10% - 100%^ | | | Other Technology | | 60,888,220 | | Most advantageous market analysis | | Most advantageous market coupon rate | | 11% - 25% | | 16% | | | Asset Recovery | | Probability weighting of alternative outcomes | | 5% - 100%^ | | | Security | | 1,279,468 | | Most advantageous market analysis | | Most advantageous market coupon rate | | 13%* | | 13% | | | Asset Recovery | | Probability weighting of alternative outcomes | | 100%^ | | | Software | | 20,039,329 | | Most advantageous market analysis | | Most advantageous market coupon rate | | 13% - 25% | | 16% | | | Asset Recovery | | Probability weighing of alternative outcomes | | 5% - 100%^ | | | Technology Services | | 1,571,859 | | Most advantageous market analysis | | Most advantageous market coupon rate | | 16%* | | 16% | | | Asset Recovery | | Probability weighing of alternative outcomes | | 5% - 75%* | | | Wireless | | 1,123,866 | | Most advantageous market analysis | | Most advantageous market coupon rate | | 16%* | | 16% | Total Loan Investments | | $129,809,562 | | | | | | | | |
(a) The weighted-average most advantageous market coupon rates were calculated using the relative fair value of the loans. * There is only one loan within this industry that utilizes this valuation technique. ^ Probability weightings vary among loan investments within each industry based on different potential future outcomes. | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Investment Type - Level 3 | | | | | | | | | Loan Investments | | Fair Value at December 31, 2024 | | Valuation Techniques / Methodologies | | Unobservable Input | | Range | | Weighted Average (a) | Biotechnology | | $3,497,275 | | Most advantageous market analysis | | Most advantageous market coupon rate | | 16% | | 16% | | | | | | | | | | | | Computers & Storage | | 10,763,242 | | Most advantageous market analysis | | Most advantageous market coupon rate | | 14% - 16% | | 14% | | | | | | | | | | | | Enterprise Networking | | 3,310,413 | | Asset Recovery | | Probability weighting of alternative outcomes | | 10% - 50% * | | | | | | | | | | | | | | Internet | | 29,154,761 | | Most advantageous market analysis | | Most advantageous market coupon rate | | 19% - 20% | | 19% | | | Asset Recovery | | Probability weighting of alternative outcomes | | 5% - 100%^ | | | | | | | | | | | | | | Medical Devices | | 310,783 | | Asset Recovery | | Probability weighting of alternative outcomes | | 100%^ | | | | | | | | | | | | | | Other Healthcare | | 4,351,720 | | Most advantageous market analysis | | Most advantageous market coupon rate | | 12% - 22% | | 17% | | | Asset Recovery | | Probability weighting of alternative outcomes | | 25% - 100%^ | | | | | | | | | | | | | | Other Technology | | 67,570,223 | | Most advantageous market analysis | | Most advantageous market coupon rate | | 11% - 38% | | 16% | | | Asset Recovery | | Probability weighting of alternative outcomes | | 5% - 100%^ | | | | | | | | | | | | | | Security | | 1,785,026 | | Most advantageous market analysis | | Most advantageous market coupon rate | | 13%* | | 13% | | | Asset Recovery | | Probability weighting of alternative outcomes | | 25% - 100%^ | | | | | | | | | | | | | | Software | | 25,664,750 | | Most advantageous market analysis | | Most advantageous market coupon rate | | 13% - 26% | | 17% | | | Asset Recovery | | Probability weighing of alternative outcomes | | 5% - 95%^ | | | | | | | | | | | | | | Technology Services | | 3,346,503 | | Most advantageous market analysis | | Most advantageous market coupon rate | | 16%* | | 16% | | | Asset Recovery | | Probability weighting of alternative outcomes | | 13% - 50%* | | | | | | | | | | | | | | Wireless | | 1,309,977 | | Most advantageous market analysis | | Most advantageous market coupon rate | | 16%* | | 16% | Total Loan Investments | | $151,064,673 | | | | | | | | |
(a) The weighted-average most advantageous market coupon rates were calculated using the relative fair value of the loans. * There is only one loan within this industry that utilizes this valuation technique. ^ Probability weightings vary among loan investments within each industry based on different potential future outcomes.
|
Schedule of Assets and Liabilities Measured at Fair Value on Recurring Basis |
The following tables present the balances of assets and liabilities as of March 31, 2025 and December 31, 2024 measured at fair value on a recurring basis:
| | | | | | | | | | | | | | | | | | | | | | | | As of March 31, 2025 | | | | | | | | ASSETS: | Level 1 | | Level 2 | | Level 3 | | Total | Loans† | $ | — | | | $ | — | | | $ | 129,809,562 | | | $ | 129,809,562 | | | | | | | | | | Cash equivalents | 6,804,113 | | | — | | | — | | | 6,804,113 | | Total | $ | 6,804,113 | | | $ | — | | | $ | 129,809,562 | | | $ | 136,613,675 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | As of December 31, 2024 | | | | | | | | ASSETS: | Level 1 | | Level 2 | | Level 3 | | Total | Loans† | $ | — | | | $ | — | | | $ | 151,064,673 | | | $ | 151,064,673 | | | | | | | | | | Cash equivalents | 4,583,701 | | | — | | | — | | | 4,583,701 | | Total | $ | 4,583,701 | | | $ | — | | | $ | 151,064,673 | | | $ | 155,648,374 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
† For a detailed listing of borrowers comprising this amount, please refer to the Condensed Schedules of Investments.
|
Schedule of Changes in Level 3 Assets Measured at Fair Value on Recurring Basis |
The following tables provide a summary of changes in Level 3 assets measured at fair value on a recurring basis:
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | For the Three Months Ended March 31, 2025 | | | Loans | | Warrants | | | | Convertible Notes | | | | | | | | | | Beginning balance | $ | 151,064,673 | | | $ | — | | | | | $ | — | | | | | | | | | | | Acquisitions and originations | — | | | 284,219 | | | | | 799,876 | | | | | | | | | | | Principal payments on loans, net of accretion | (17,986,661) | | | — | | | | | — | | | | | | | | | | | | | | | | | | | | | | | | | | | | Distributions to shareholder | — | | | (284,219) | | | | | (799,876) | | | | | | | | | | | Net realized loss from loans | (734,522) | | | — | | | | | — | | | | | | | | | | | Net change in unrealized loss from loans | (2,533,928) | | | — | | | | | — | | | | | | | | | | | Ending balance | $ | 129,809,562 | | | $ | — | | | | | $ | — | | | | | | | | | | | Net change in unrealized loss from loans still held at March 31, 2025 | $ | (3,506,431) | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | For the Three Months Ended March 31, 2024 | | | Loans | | Warrants | | Stocks | | Convertible Notes | | | | | | | | Beginning balance | $ | 302,804,781 | | | $ | — | | | $ | — | | | $ | — | | | | | | | | | Acquisitions and originations | 496,047 | | | 266,643 | | | 75,814 | | | 300,000 | | | | | | | | | Principal payments on loans, net of accretion | (44,602,650) | | | — | | | — | | | — | | | | | | | | | | | | | | | | | | | | | | | | Distributions to shareholder | — | | | (266,643) | | | (75,814) | | | (300,000) | | | | | | | | | Net realized loss from loans | — | | | — | | | — | | | — | | | | | | | | | Net change in unrealized loss from loans | (5,331,734) | | | — | | | — | | | — | | | | | | | | | Ending balance | $ | 253,366,444 | | | $ | — | | | $ | — | | | $ | — | | | | | | | | | Net change in unrealized loss from loans still held at March 31, 2024 | $ | (5,331,734) | | | | | | | | | | | | | | |
|